Clinical Trial Update: A Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus [Phase 2]

View source ↗

Summary

This document provides a clinical trial update on a Phase II study of Afatinib in metastatic or recurrent squamous cell carcinoma of the esophagus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Esophagus

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Yonsei University | Conditions: Squamous Cell Carcinoma of Esophagus | Phase 2 | Status: UNKNOWN